Before the COVID-19 pandemic, many people weren’t aware of the critical role cold chain logistics played, particularly for temperature-sensitive biopharmaceuticals. This changed when the media highlighted the complex logistics involved in transporting mRNA-based vaccines, which required ultracold supply chain solutions to preserve their safety and efficacy as they traveled worldwide to patients in need. These discussions underscored how important temperature control is for preserving the integrity of these products.

As the demand for temperature-sensitive therapies rises, robust cold chain logistics have become essential to ensuring product safety and efficacy. Even brief temperature deviations can compromise these drugs, leading to costly recalls, wasted resources, and risks to patient safety. According to the World Health Organization (WHO), nearly 50% of vaccines are wasted annually due to improper temperature management. Further, the global cost of pharmaceutical cold chain failures is estimated at $35 billion annually.

These figures underscore the critical importance of maintaining precise and reliable temperature control at every stage of the supply chain.

Download the full article to read more.